ENType 1 diabetes treatment in Germany means lifelong insulin therapy set up precisely for the person: type 1 diabetes is an autoimmune condition in which the immune system destroys the insulin-producing cells of the pancreas, so insulin has to be given from outside. It is not advanced type 2 diabetes and is not caused by diet.
People come to Germany not for a way out of the disease but to fine-tune the insulin regimen, choose a pump and continuous glucose monitoring, and complete structured education that lets them manage on their own. Many readers hope for a cure, so it is fair to say at once: no clinic can take you off insulin.
Is there a cure for type 1 diabetes in Germany?
No: there is no cure for type 1 diabetes in Germany or anywhere else today. As the WHO fact sheet on diabetes puts it, people with type 1 diabetes need insulin to survive. Many families arrive after looking up “type one diabetes cure in Germany”; anyone who promises to make insulin unnecessary is not describing routine care.
What does exist is narrow. Islet cell transplantation, which transfers insulin-producing cells from a deceased donor, is offered only to people who have had life-threatening hypoglycaemia or who receive or already have a kidney transplant and take immune-suppressing drugs anyway. Stem cell treatment for type 1 diabetes in Germany remains confined to clinical trials with strict entry criteria: research studies that test whether a new treatment is safe and works. A place in a trial is not a service you can buy.
The honest answer still leaves a reason to travel: a well-set regimen with the right devices and training often brings fewer lows and steadier readings, even though the injections stay. No one can promise a particular result.
Confirming the type of diabetes
In Germany the type is confirmed with blood tests and, if doubts remain, a genetic test. Type 1 diabetes usually shows up with strong thirst, frequent urination, unexplained weight loss and weakness. In children it is often first found during ketoacidosis: without insulin the body burns fat, the blood turns acidic and urgent hospital care is needed. The cause is an inherited predisposition plus a trigger not fully understood, so it cannot be prevented by diet or lifestyle, and parents are not to blame.
The type is re-checked even when a diagnosis exists, because the whole plan depends on it and errors are more common than people expect. Type 2 diabetes, in which the body makes insulin but responds to it poorly, is a different disease; the page on diabetes treatment in Germany covers both. An adult with autoimmune diabetes may stay too long on tablets, and a young person with an inherited form may get insulin they do not need.
Doctors measure blood glucose and HbA1c, the average sugar level over the past two to three months; C-peptide, which shows how much of the body’s own insulin is left; and antibodies to GAD, IA-2 and ZnT8, traces of the immune attack on insulin-producing cells. If antibodies are present, the diabetes is most likely autoimmune; their absence does not rule out type 1.
LADA, the slowly developing autoimmune diabetes of adults, starts gently and is often first treated as type 2. MODY, a group of inherited forms caused by a single gene, is looked for with genetic testing when diabetes started young without antibodies and close relatives are affected. Correcting the type can change treatment completely: some forms of MODY respond to tablets instead of insulin, and some may need no treatment. More on the tests is on the page about diabetes diagnostics.
What the treatment consists of
Treatment rests on the basal-bolus regimen: long-acting insulin covers background needs between meals and overnight, while short-acting insulin is given for meals and corrections. Doses are worked out individually: the background dose, the carbohydrate ratio (units per portion of carbohydrate) and the correction factor. At the m&i Specialty Clinic Bad Heilbrunn, for example, this is the work of the department of diabetes and metabolic diseases, whose head physician is Dr Andreas Liebl, a diabetologist.
The second part is technology: an insulin pump delivers short-acting insulin continuously through a thin cannula, and a continuous glucose monitor (CGM) measures sugar every few minutes and warns of lows. In automated insulin delivery (AID) systems the two talk to each other: an algorithm lowers or pauses insulin when sugar falls and adds it when sugar rises. Whether this suits a patient depends on how often lows occur, daily routine and readiness to work with a device every day.
The realistic aim is fewer night-time lows and steadier readings, not the end of injections or self-monitoring: carbohydrates still have to be counted, sensors changed, and a pen kept ready in case the technology fails.
Diabetes education and screening for complications
Education teaches patients to manage the disease themselves, and screening finds complications before symptoms appear. The German structured education course is taught by diabetologists and diabetes educators, and the German Diabetes Society (DDG) certifies such programmes. Patients learn carbohydrate counting and what to do during a low, during illness, when travelling and when exercising; for an international patient this is often the most valuable part of the trip.
Routine checks cover the retina, the kidneys (protein in the urine), the feet and nerve sensation, blood pressure and lipids. They are done before symptoms appear, because damage to vessels and nerves develops silently, and changes found early are easier to treat.
When complications are already present, specialists join in: an ophthalmologist treats retinal changes with laser or injections into the eye, a nephrologist follows the kidneys, and a specialised diabetic foot unit treats ulcers or deformities of the foot. In Germany such units are certified by the DDG. The aim is to preserve sight, the kidneys and the foot, though no outcome can be promised.
Children and teenagers
A child with type 1 diabetes needs a paediatric diabetologist: the disease most often begins in childhood or young adulthood, and doses are recalculated as the child grows, with insulin needs rising noticeably in puberty. Education covers both the child and the parents, who make the dosing decisions while the child is small.
Families discuss a pump and sensor for a small child, school, sport and, for teenagers, the handover to adult care. This is the daily work of paediatric diabetes centres, such as the centre for children and adolescents at DRK Kliniken Berlin, led by Dr Silvia Müther, paediatric diabetologist.
Frequently asked questions
What is stem cell therapy for diabetes?
Stem cell therapy for type 1 diabetes is still a research treatment, not standard care. In clinical trials, insulin-producing cells grown from stem cells are transplanted into patients with severe hypoglycaemia, usually with immune-suppressing drugs. A paid offer to “cure diabetes with stem cells” is a reason for caution.
What new treatments for diabetes are there?
The most visible change in type 1 diabetes care is automated insulin delivery, in which the pump adjusts insulin to sensor readings. The EU has also authorised teplizumab, which in adults and children from the age of eight at an early, symptom-free stage of type 1 diabetes can delay the onset of the disease. No treatment yet makes diabetes go away.
What should I bring to the first appointment?
Bring discharge letters, recent test results, sensor or pump reports and a list of all medicines with doses. Pack insulin and supplies for the whole trip plus a reserve, and ask your doctor for a letter confirming that you carry insulin and devices for airport security.
How AlenMed arranges treatment
AlenMed starts with a remote review of your records and self-monitoring logs, translated for the clinic’s doctors. We then choose a department among the endocrinology clinics in Germany: a diabetes centre certified by the DDG, and for a child a paediatric diabetes centre, such as the one led by Dr Silvia Müther at DRK Kliniken Berlin, which the DDG has certified as a centre of excellence for paediatric diabetology. Then come appointments, a cost estimate, the visa and an interpreter. The estimate covers consultations and tests, the education course and setting up the devices; the clinic states in it which devices and supplies are included and which are charged separately.
The patient takes home a written insulin regimen, the device settings and a follow-up plan, and can send questions to the clinic later through AlenMed.
This material is for information only and is not an offer. The insulin regimen is set by a doctor at an in-person consultation.
News on this topic
International Consensus Recommends Pediatric Screening for Type 1 Diabetes
Experts have established consensus guidelines for early pediatric screening for type 1 diabetes to prevent severe complications and enable timely intervention.
